| Trial ID: | L0757 |
| Source ID: | NCT00823303
|
| Associated Drug: |
Paricalcitol
|
| Title: |
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
|
| Acronym: |
PACE
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00823303/results
|
| Conditions: |
Secondary Hyperparathyroidism|Chronic Kidney Disease
|
| Interventions: |
DRUG: Paricalcitol|DRUG: Calcitriol
|
| Outcome Measures: |
Primary: Confirmed Hypercalcemia, Serum Calcium 10.5 mg/dL or higher, confirmed by repeat measurement., 24 week treatment period |
|
| Sponsor/Collaborators: |
Sponsor: Washington University School of Medicine | Collaborators: Henry Ford Hospital|Northwestern University Feinberg School of Medicine|Endeavor Health|Abbott
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
110
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-02
|
| Completion Date: |
2013-09
|
| Results First Posted: |
2014-08-05
|
| Last Update Posted: |
2014-08-07
|
| Locations: |
Northwestern University, Chicago, Illinois, 60611, United States|Northshore University Health System, Evanston, Illinois, 60201, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Washington University, St. Louis, Missouri, 63110, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00823303
|
